BioCentury | Oct 6, 2018
Finance

Seeking validation

...S.A. (Euronext:DBV; NASDAQ:DBVT) Viaskin Peanut (DBV-712) Peanut allergy in children ages 4-11 Submit BLA 4Q18 Diurnal...
BioCentury | Jun 30, 2018
Finance

Eyes on launches

...S.A. (NASDAQ:DBVT; Euronext:DBV) Viaskin Peanut (DBV-712) Peanut allergy in children ages 6-11 Submit BLA 2H18 Diurnal...
BioCentury | Jun 20, 2018
Company News

Management tracks: Sanofi, NantKwest

...He is non-executive chairman at Clinigen Group plc (LSE:CLIN), Advanced Medical Solutions Group plc (LSE:AMS), Diurnal...
BioCentury | Apr 6, 2018
Finance

Fundamentally driven

...impairment in patients with chronic inflammatory demyelinating polyneuropathy, an autoimmune disorder that affects peripheral nerves Diurnal...
BioCentury | Feb 16, 2018
Clinical News

EC approves Diurnal's Alkindi

...as a replacement therapy to treat adrenal insufficiency in individuals less than 18 years old. Diurnal...
...granule formulation of hydrocortisone. Diurnal Group plc (LSE:DNL), Cardiff, U.K. Product: Alkindi (Infacort) Business: Endocrine/Metabolic Sandi Wong Alkindi Diurnal Ltd. Adrenal...
BioCentury | Feb 13, 2018
Company News

EC approves Diurnal's Alkindi

...as a replacement therapy to treat adrenal insufficiency in individuals less than 18 years old. Diurnal...
...it was "too early" to discuss pricing. Alkindi is a dry granule formulation of hydrocortisone. Sandi Wong Alkindi Diurnal Ltd. Adrenal...
BioCentury | Dec 22, 2017
Clinical News

CHMP recommends Diurnal's Alkindi for pediatric adrenal insufficiency

...EMA's CHMP recommended approval of Alkindi (Infacort) from Diurnal Ltd. (Cardiff, U.K.) as replacement therapy for pediatric...
...a dry granule formulation of hydrocortisone. Diurnal Ltd., Cardiff, U.K. Product: Alkindi (Infacort) Business: Endocrine/Metabolic Elizabeth S. Eaton hydrocortisone Infacort Diurnal Ltd. Alkindi...
BioCentury | Sep 28, 2017
Translation in Brief

Bugs on the clock

Researchers from University of Texas Southwestern Medical Center have discovered a link between the gut microbiome and the circadian mechanisms that regulate body fat storage. Their findings implicate nuclear factor interleukin-3 regulated (NFIL3) as a...
BioCentury | Jun 2, 2017
Clinical News

Aerie's Roclatan meets in second Phase III for IOP

...8% for latanoprost (p<0.0001 for both). Furthermore, 56% of patients receiving Roclatan achieved a mean diurnal...
BioCentury | Apr 20, 2017
Company News

Diurnal, Clinigen sales and marketing update

...Clinigen launched a patient access program in Europe to provide Diurnal’s cortisol deficiency candidates Infacort and...
...adults with congenital adrenal hyperplasia. Diurnal expects to complete the trial in 2018. According to Diurnal...
...hyperplasia. Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Diurnal Ltd. , Cardiff, U.K. Business: Endocrine/Metabolic Meghan Sullivan Chronocort Infacort Clinigen Group plc Diurnal Ltd....
Items per page:
1 - 10 of 55
BioCentury | Oct 6, 2018
Finance

Seeking validation

...S.A. (Euronext:DBV; NASDAQ:DBVT) Viaskin Peanut (DBV-712) Peanut allergy in children ages 4-11 Submit BLA 4Q18 Diurnal...
BioCentury | Jun 30, 2018
Finance

Eyes on launches

...S.A. (NASDAQ:DBVT; Euronext:DBV) Viaskin Peanut (DBV-712) Peanut allergy in children ages 6-11 Submit BLA 2H18 Diurnal...
BioCentury | Jun 20, 2018
Company News

Management tracks: Sanofi, NantKwest

...He is non-executive chairman at Clinigen Group plc (LSE:CLIN), Advanced Medical Solutions Group plc (LSE:AMS), Diurnal...
BioCentury | Apr 6, 2018
Finance

Fundamentally driven

...impairment in patients with chronic inflammatory demyelinating polyneuropathy, an autoimmune disorder that affects peripheral nerves Diurnal...
BioCentury | Feb 16, 2018
Clinical News

EC approves Diurnal's Alkindi

...as a replacement therapy to treat adrenal insufficiency in individuals less than 18 years old. Diurnal...
...granule formulation of hydrocortisone. Diurnal Group plc (LSE:DNL), Cardiff, U.K. Product: Alkindi (Infacort) Business: Endocrine/Metabolic Sandi Wong Alkindi Diurnal Ltd. Adrenal...
BioCentury | Feb 13, 2018
Company News

EC approves Diurnal's Alkindi

...as a replacement therapy to treat adrenal insufficiency in individuals less than 18 years old. Diurnal...
...it was "too early" to discuss pricing. Alkindi is a dry granule formulation of hydrocortisone. Sandi Wong Alkindi Diurnal Ltd. Adrenal...
BioCentury | Dec 22, 2017
Clinical News

CHMP recommends Diurnal's Alkindi for pediatric adrenal insufficiency

...EMA's CHMP recommended approval of Alkindi (Infacort) from Diurnal Ltd. (Cardiff, U.K.) as replacement therapy for pediatric...
...a dry granule formulation of hydrocortisone. Diurnal Ltd., Cardiff, U.K. Product: Alkindi (Infacort) Business: Endocrine/Metabolic Elizabeth S. Eaton hydrocortisone Infacort Diurnal Ltd. Alkindi...
BioCentury | Sep 28, 2017
Translation in Brief

Bugs on the clock

Researchers from University of Texas Southwestern Medical Center have discovered a link between the gut microbiome and the circadian mechanisms that regulate body fat storage. Their findings implicate nuclear factor interleukin-3 regulated (NFIL3) as a...
BioCentury | Jun 2, 2017
Clinical News

Aerie's Roclatan meets in second Phase III for IOP

...8% for latanoprost (p<0.0001 for both). Furthermore, 56% of patients receiving Roclatan achieved a mean diurnal...
BioCentury | Apr 20, 2017
Company News

Diurnal, Clinigen sales and marketing update

...Clinigen launched a patient access program in Europe to provide Diurnal’s cortisol deficiency candidates Infacort and...
...adults with congenital adrenal hyperplasia. Diurnal expects to complete the trial in 2018. According to Diurnal...
...hyperplasia. Clinigen Group plc (LSE:CLIN), Burton-on-Trent, U.K. Diurnal Ltd. , Cardiff, U.K. Business: Endocrine/Metabolic Meghan Sullivan Chronocort Infacort Clinigen Group plc Diurnal Ltd....
Items per page:
1 - 10 of 55